The stock opened at Rs 920.0 and touched an intraday high and low of Rs 927.55 and Rs 915.5, respectively, in the session so far. The stock of Aurobindo Pharma Ltd. quoted a 52-week high of Rs 1063.75 and a 52-week low of Rs 737.9.
Total market cap of the Aurobindo Pharma Ltd. stood at Rs 53795.02 crore at the time of writing this report.
The company reported consolidated net sales of Rs 6079.6 crore for the quarter ended 31-Mar-2021, down 6.44 per cent from previous quarter’s Rs 6498.31 crore and down 1.8 per cent from the year-ago quarter’s Rs 6191.02 crore.
The net profit for latest quarter stood at Rs 801.58 crore, down 5.68 per cent from the same quarter a year ago.
As of 30-Jun-2021, DIIs held 9.03 per cent stake in the company, while foreign institutional investors held 25.65 per cent and the promoters 51.83 per cent.
According to BSE data, the stock traded at a price-to-earnings multiple of 10.08 and a price-to-book ratio of 1.44. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Aurobindo Pharma Ltd. belongs to the Pharma – Indian industry.
Business News Governmental News Finance News
Need Your Help Today. Your $1 can change life.